Novel


Journal

Open biology
ISSN: 2046-2441
Titre abrégé: Open Biol
Pays: England
ID NLM: 101580419

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 29 10 2024
Statut: ppublish

Résumé

The development of therapies to combat neurodegenerative diseases is widely recognized as a research priority. Despite recent advances in understanding their molecular basis, there is a lack of suitable early biomarkers to test selected compounds and accelerate their translation to clinical trials. We have investigated the utility of

Identifiants

pubmed: 39471842
doi: 10.1098/rsob.240073
doi:

Substances chimiques

DNA-Binding Proteins 0
NF-E2-Related Factor 2 0
TARDBP protein, human 0
Biomarkers 0
Tardbp protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

240073

Subventions

Organisme : MND Scotland
Organisme : ARUK

Auteurs

Febe Ferro (F)

Systems and Cellular Medicine, University of Dundee, Dundee DD1 9SY, UK.

C Roland Wolf (CR)

Systems and Cellular Medicine, University of Dundee, Dundee DD1 9SY, UK.

Christopher Henstridge (C)

Systems and Cellular Medicine, University of Dundee, Dundee DD1 9SY, UK.

Francisco Inesta-Vaquera (F)

Systems and Cellular Medicine, University of Dundee, Dundee DD1 9SY, UK.
Department of Biochemistry and Molecular Biology and Genetics, University of Extremadura, Badajoz 06006, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH